Micro-injection robot for 3D cell cultures
For injection of small droplets of cells into a hydrogel.
Quick facts
Creation of cell spheroids in a gel matrix
Programmable injection patterns
On-site training included
Protocol
For this application, cells from culture or tissue are dissociated, washed and filtered into a single cell suspension. The suspension is pipetted into a well of a 96 or 384 well plate. In the same or another plate, wells are pre-filled with e.g. collagen gel and using a set volume and location multiple wells are automatically injected with droplets of cells.
Known applications
Cancer cell spheroid migration assay
Using droplets of about 300 micrometer diameter (±10k cells) cells in the core of the spheroid will die, and act as a trigger to start migration of cells. The droplet diameter as well as the outgrowth is reproducible, making this method suitable for high content screening assays. Typical time needed for one screen is approximately 3 (cell culture cells) to 8 (primary cells) days.
Cell-cell interaction assay
In this application, cell spheroids are placed at a predefined distance of each other in a gel, and the cell-cell interaction can be studied using e.g. confocal microscopy. In addition to the distance also the time between injections can be varied, depending on your application. Using multiple cell types in one well, more complex tissues can be formed and studied.
Pricing and ordering
Based on your request and application there are different options available that will affect the price. Therefore, pricing information is only available on request. Academic discount is available, and the purchase includes on-site installation and two days of training. Commercial use requires a yearly license and service contract.
For ordering or more information, please contact us here.
Publications
2024
TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancerDian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers, Daphne Roelofs, Kim Kroese, Mieke M. Timmermans, Chen-Yi Liao, Shaozhuo Huang, Anita Trapman-Jansen, Renee Foekens, Justine Michaux, Monique T.A. de Beijer, Sonja I. Buschow, Jeroen AA. Demmers, Marleen Kok, Erik HJ. Danen, Michal Bassani-Sternberg, John W.M. Martens, Rachel J.M. Abbott and Reno DebetsCancer Discovery(open access)
2023
Cancer-Associated Fibroblasts Are Key Determinants of Cancer Cell Invasion in the Earliest Stage of Colorectal CancerHao Dang, Tom J. Harryvan, Chen-Yi Liao, Erik H.J. Danen, Vienna N.L.N. Spalburg, Szymon M. Kielbasa, Hailiang Mei, Jelle J. Goeman, Eveline S. de Jonge-Muller, Stefanus G.T. Janson, Johan J. van der Reijden, Stijn Crobach, James C.H. Hardwick, Jurjen J. Boonstra, Noel F.C.C. de Miranda and Lukas J.A.C. HawinkelsCellular and Molecular Gastroenterology and Hepatology(open access)
2014
SYK is a candidate kinase target for the treatment of advanced prostate cancerVeerander Paul Singh Ghotra, Shuning He, Geertje van der Horst, Steffen Nijhoff, Hans de Bont, Annemarie Lekkerkerker, Richard Janssen, Guido Jenster, Geert JLH van Leenders, Agnes Marije M. Hoogland, Esther I Verhoef, Zuzanna Baranski, Jiangling Xiong, Bob van de Water, Gabri van der Pluijm, Ewa Snaar-Jagalska and Erik DanenCancer Research
β1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGFβ–miR-200–ZEB Network in E-Cadherin–Positive Triple-Negative Breast CancerHoa H. Truong, Jiangling Xiong, Veerander P. S. Ghotra, Ella Nirmala, Lizette Haazen, Sylvia E. Le Dévédec, Hayri E. Balcioğlu, Shuning He, B. Ewa Snaar-Jagalska, Erno Vreugdenhil, John H. N. Meerman, Bob van de Water, Erik H. J. DanenScience Signaling